Skip to search.
 TSX Down 0.42% TSX Ventures Down 1.09%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
1.87 Down 0.09(4.59%) Apr 27, 4:00PM EDT
Add to Portfolio
Prev Close:1.96
Open:1.96
Bid:1.84 x 2100
Ask:2.18 x 300
1y Target Est:5.63
Beta:1.64
Next Earnings Date: 6-May-15CTIC Earnings announcement
Day's Range:1.86 - 1.97
52wk Range:1.77 - 3.23
Volume:1,761,450
Avg Vol (3m):3,529,060
Market Cap:324.83M
P/E (ttm):N/A
EPS (ttm):-0.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CTICDown 4.59%324.83M
BMYDown 0.97%108.60B
RHHBYDown 0.10%N/A
SNYUp 1.02%136.71B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.67
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.46
Quarterly EPS Est (Mar-15) :-0.14
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback